ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 55 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2015. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,318,000 | +46.0% | 180,582 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $903,000 | -1.0% | 180,582 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $912,000 | -18.6% | 180,582 | 0.0% | 0.01% | -11.1% |
| Q3 2017 | $1,120,000 | +72.3% | 180,582 | 0.0% | 0.01% | +50.0% |
| Q2 2017 | $650,000 | +10.7% | 180,582 | 0.0% | 0.01% | +20.0% |
| Q1 2017 | $587,000 | +32.8% | 180,582 | 0.0% | 0.01% | +25.0% |
| Q4 2016 | $442,000 | -28.8% | 180,582 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $621,000 | -1.1% | 180,582 | 0.0% | 0.01% | -14.3% |
| Q2 2016 | $628,000 | -15.8% | 180,582 | 0.0% | 0.01% | -12.5% |
| Q1 2016 | $746,000 | -7.2% | 180,582 | 0.0% | 0.01% | +14.3% |
| Q4 2015 | $804,000 | -26.9% | 180,582 | 0.0% | 0.01% | -30.0% |
| Q3 2015 | $1,100,000 | – | 180,582 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 260,000 | $866,000 | 0.34% |
| RTW INVESTMENTS, LP | 5,978,355 | $19,908,000 | 0.31% |
| GSA CAPITAL PARTNERS LLP | 309,839 | $1,032,000 | 0.17% |
| QCM Cayman, Ltd. | 12,728 | $42,000 | 0.13% |
| COWEN AND COMPANY, LLC | 486,717 | $1,621,000 | 0.11% |
| Hudson Bay Capital Management LP | 1,400,000 | $4,662,000 | 0.06% |
| Kerrisdale Advisers, LLC | 208,150 | $693,000 | 0.05% |
| Secure Asset Management, LLC | 10,000 | $33,000 | 0.02% |
| PDT Partners, LLC | 72,500 | $241,000 | 0.02% |
| Point72 Asset Management, L.P. | 1,037,700 | $3,456,000 | 0.02% |